On December 12, 2024, Elimelech Rosner, Executive Vice President and Chief Technology Officer at HealthEquity Inc, executed a sale of 2,869 shares of HealthEquity Inc (HQY, Financial). Following this transaction, the insider now holds 57,195 shares of the company. The details of this transaction can be found in the SEC Filing.
HealthEquity Inc is a company that provides a range of solutions for managing health savings accounts (HSAs) and other consumer-directed benefits. The company offers a platform that allows consumers to access their health savings and spending accounts, providing tools for managing healthcare expenses and maximizing savings.
Over the past year, Elimelech Rosner has sold a total of 15,165 shares and has not made any purchases. The insider transaction history for HealthEquity Inc indicates that there have been no insider buys and 22 insider sells over the same period.
On the day of the recent sale, shares of HealthEquity Inc were trading at $97.12, giving the stock a market cap of $8.287 billion. The company's price-earnings ratio stands at 87.72, which is higher than the industry median of 22.775 but lower than the company's historical median price-earnings ratio.
With a trading price of $97.12 and a GuruFocus Value of $84.78, HealthEquity Inc has a price-to-GF-Value ratio of 1.15, indicating that the stock is modestly overvalued based on its GF Value. The GF Value is an intrinsic value estimate developed by GuruFocus, calculated using historical multiples such as the price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow. It also considers a GuruFocus adjustment factor based on the company's past returns and growth, as well as future estimates of business performance from Morningstar analysts.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
